NCT01624870

CoreValve Advance-II Study: Prospective International Post-market Study

CoreValve Advance-II Study: Best Practices Investigation of Patients Implanted With the Medtronic CoreValve Bioprosthesis.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 200 (actual)
• Sponsor: Medtronic Cardiac Rhythm and Heart Failure · Industry
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

The CoreValve ADVANCE-II Study is a best practices investigation of patients implanted with the Medtronic CoreValve bioprosthesis.

Detailed description

The purpose of the study was to investigate the rate of conduction disturbances after trans-catheter aortic valve implantation of the Medtronic CoreValve device, aiming to characterize best practices. The investigators did not assign study specific interventions to the subjects in the study.

Conditions

• Aortic Valve Stenosis
• Valvular Heart Disease

Timeline

• Start date: 2011-10-01
• Primary completion: 2013-10-01
• Completion: 2014-03-01
• First posted: 2012-06-21
• Last updated: 2018-09-19
• Results posted: 2018-07-30

Locations

9 sites across 6 countries: Belgium, Czechia, Germany, Italy, Netherlands, United Kingdom